<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Although microsomal <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E synthase (mPGES)-1 is known to contribute to <z:hpo ids='HP_0001297'>stroke</z:hpo> injury, the underlying mechanisms remain poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>This study examines the hypothesis that EP(3) receptors contribute to <z:hpo ids='HP_0001297'>stroke</z:hpo> injury as downstream effectors of mPGES-1 neurotoxicity through Rho kinase activation </plain></SENT>
<SENT sid="2" pm="."><plain>EXPERIMENTAL APPROACH: We used a <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced excitotoxicity model in cultured rat and mouse hippocampal slices and a mouse middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>-reperfusion model </plain></SENT>
<SENT sid="3" pm="."><plain>Effects of an EP(3) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> on neuronal damage in mPGES-1 knockout (KO) mice was compared with that in <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) mice </plain></SENT>
<SENT sid="4" pm="."><plain>KEY RESULTS: In cultures of rat hippocampal slices, the <z:chebi fb="2" ids="33699">mRNAs</z:chebi> of EP(1-4) receptors were constitutively expressed and only the EP(3) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> ONO-AE3-240 attenuated and only the EP(3) receptor <z:chebi fb="4" ids="48705">agonist</z:chebi> ONO-AE-248 augmented <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced excitotoxicity in CA1 neurons </plain></SENT>
<SENT sid="5" pm="."><plain>Hippocampal slices from mPGES-1 KO mice showed less excitotoxicity than those from WT mice and the EP(3) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> did not attenuate the excitotoxicity </plain></SENT>
<SENT sid="6" pm="."><plain>In transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> models, injection (i.p.) of an EP(3) <z:chebi fb="68" ids="48706">antagonist</z:chebi> reduced infarction, <z:hpo ids='HP_0000969'>oedema</z:hpo> and neurological dysfunction in WT mice, but not in mPGES-1 KO mice, which showed less injury than WT mice </plain></SENT>
<SENT sid="7" pm="."><plain>EP(3) receptor <z:chebi fb="4" ids="48705">agonist</z:chebi>-induced augmentation of excitotoxicity in vitro was ameliorated by the Rho kinase inhibitor Y-27632 and <z:e sem="disease" ids="C0043167" disease_type="Disease or Syndrome" abbrv="">Pertussis</z:e> toxin </plain></SENT>
<SENT sid="8" pm="."><plain>The Rho kinase inhibitor HA-1077 also ameliorated <z:hpo ids='HP_0001297'>stroke</z:hpo> injury in vivo </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION AND IMPLICATIONS: Activity of mPGES-1 exacerbated <z:hpo ids='HP_0001297'>stroke</z:hpo> injury through EP(3) receptors and activation of Rho kinase and/or G(i) </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, mPGES-1 and EP(3) receptors may be valuable therapeutic targets for treatment of human <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>